Clinical Trials: Efficacy of Besifloxacin Ophthalmic Suspension in the Treatment of Bacterial Conjunctivitis

Article

This clinical trial will determine if Besifloxacin Ophthalmic Solution is an effective treatment for bacterial conjunctivitis.

Click here to access this third-party resource:

Efficacy of Besifloxacin Ophthalmic Suspension in the Treatment of Bacterial Conjunctivitis

Study Type: Interventional

Age/Gender Requirements: 1 year+ (male/female)

Sponsor: Bausch & Lomb, Inc.

Purpose: This study will evaluate “the clinical and microbial efficacy of besifloxacin ophthalmic suspension compared with vehicle” for the treatment of bacterial conjunctivitis.

Related Videos
Vlado Perkovic, MBBS, PhD | Credit: George Institute of Global Health
Elizabeth Aby, MD | Credit: Minnesota Health Fairview
Video 3 - "Insights Gleaned from Asthma Research for COPD"
Video 3 - "Insights Gleaned from Asthma Research for COPD"
Video 3 - "HIV Treatment: Discussing Adverse Events with Patients"
Prashant Singh, MD | Credit: University of Michigan
Sean Adrean, MD: Impact of Baseline VA on Aflibercept 8 mg Outcomes in DME | Image Credit: Linkedin
Video 3 - "Key Clinical Considerations in HIV Treatment Decisions"
© 2024 MJH Life Sciences

All rights reserved.